Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters









Database
Language
Publication year range
1.
Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines.
Koumaki, Dimitra; Marinos, Leonidas; Nikolaou, Vasiliki; Papadakis, Marios; Zografaki, Kyriaki; Lagoudaki, Eleni; Kotopouli, Frantzeska-Eleni; Krasagakis, Konstantinos; Krueger-Krasagakis, Sabine-Elke.
Int J Dermatol ; 61(7): 900-902, 2022 07.
Article in English | MEDLINE | ID: mdl-35584258

Subject(s)
COVID-19 , Lymphomatoid Papulosis , Skin Neoplasms , BNT162 Vaccine , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , ChAdOx1 nCoV-19 , Humans , Lymphomatoid Papulosis/diagnosis
2.
Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia.
Koumaki, Dimitra; Koumaki, Vasiliki; Haniotis, Vrettos; Katoulis, Alexander; Boumpoucheropoulos, Sotirios; Stefanidou, Maria; Pontikoglou, Charalampos; Bertsias, George; Evangelou, George; Zografaki, Kyriaki; Mantaka, Aikaterini; Krueger-Krasagakis, Sabine Elke; Krasagakis, Konstantinos.
Indian J Dermatol ; 66(1): 108-112, 2021.
Article in English | MEDLINE | ID: mdl-33911310
3.
Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab.
Koumaki, Dimitra; Koumaki, Vasiliki; Katoulis, Alexander; Lagoudaki, Eleni; Boumpoucheropoulos, Sotirios; Stefanidou, Maria; Miaris, Orestis; Baltaga, Ludmila; Evangelou, George; Zografaki, Kyriaki; Krueger-Krasagakis, Sabine-Elke; Krasagakis, Konstantinos.
Dermatol Ther ; 33(4): e13791, 2020 07.
Article in English | MEDLINE | ID: mdl-32510744

Subject(s)
Crohn Disease , Psoriasis , Adalimumab/adverse effects , Alopecia/chemically induced , Alopecia/diagnosis , Alopecia/drug therapy , Crohn Disease/diagnosis , Crohn Disease/drug therapy , Humans , Psoriasis/chemically induced , Psoriasis/diagnosis , Psoriasis/drug therapy , Scalp , Ustekinumab/adverse effects
4.
Hydroxychloroquine-induced erythema multiforme.
Koumaki, Dimitra; Koumaki, Vasiliki; Bertsias, George; Boumpoucheropoulos, Sotirios; Katoulis, Alexander; Stefanidou, Maria; Miaris, Orestis; Evangelou, George; Zografaki, Kyriaki; Krueger-Krasagakis, Sabine Elke; Krasagakis, Konstantinos.
Clin Case Rep ; 8(3): 578-579, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32185066

ABSTRACT

Hydroxychloroquine is a commonly used medication and rarely may result in development of erythema multiforme. This potential cutaneous side effect should be highlighted in information given to patients prior to hydroxychloroquine commencement.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL